Nu-Med Plus, Inc. filed a preliminary proxy statement with the U.S. Securities and Exchange Commission for its 2026 virtual annual meeting of stockholders, presenting eleven substantive proposals including a corporate name change, reincorporation, and a reverse stock split.

Key Highlights

  • Name change proposed: Stockholders will vote on changing the company name from "Nu-Med Plus, Inc." to "Avid Gold, Inc."
  • Reverse stock split: The filing proposes a 1-for-27 reverse split of issued and outstanding common stock, par value $0.001 per share.
  • Reincorporation: The company is seeking stockholder approval to reincorporate from the State of Utah to the State of Nevada.
  • Authorized share increases: Proposals include increasing authorized common shares from 90,000,000 to 500,000,000 and authorized preferred shares from 10,000,000 to 20,000,000.
  • 2026 Equity Incentive Plan: Stockholders will consider adopting the Nu-Med Plus, Inc. 2026 Equity Incentive Plan.
  • Auditor ratification: The board proposes ratifying the appointment of Fruci & Associates II, PPLC as independent auditors for the fiscal year ending December 31, 2026.
  • Board recommendation: The Board of Directors unanimously recommends voting "For All" on the director election and "For" on each of the restructuring proposals.

Nu-Med Plus Puts Sweeping Corporate Restructuring to a Stockholder Vote

According to the preliminary proxy statement, Nu-Med Plus, Inc., a Utah corporation headquartered at 640 Belle Terre Rd., Building 2 E, Port Jefferson, NY 11777, has called a 2026 virtual annual meeting to seek stockholder approval on eleven distinct proposals. The filing was signed by Chairman William Hayde and references the company's Annual Report on Form 10-K for the year ended December 31, 2025 as an accompanying document. No specific meeting date is listed in the filing, as placeholders remain throughout the document.

The most significant proposals center on a fundamental repositioning of the company. The Name Change Proposal would replace the "Nu-Med Plus, Inc." identity with "Avid Gold, Inc.," while the Reincorporation Proposal would shift the company's legal domicile from Utah to Nevada. Concurrent with those changes, the filing asks stockholders to approve a 1-for-27 reverse stock split of common shares, par value $0.001 per share. The Authorized Common Share Increase Proposal would expand the pool of issuable common shares from 90,000,000 to 500,000,000, and a parallel preferred share increase would move that ceiling from 10,000,000 to 20,000,000.

The proxy statement also includes routine annual meeting items. Stockholders will elect three directors, each to serve a one-year term. A non-binding Say on Pay vote on named executive officer compensation is included, along with an advisory vote on the frequency of future such votes, for which the Board recommends a "3 Years" cadence. An Adjournment Proposal is included to allow the meeting to be extended if sufficient votes are not obtained on the restructuring items. The annual meeting will be conducted exclusively in a virtual, audio teleconference format, with no in-person attendance option available.

What Was Disclosed

Nu-Med Plus, Inc. filed a preliminary proxy statement for its 2026 annual stockholder meeting, disclosing proposals covering a corporate name change to Avid Gold, Inc., a 1-for-27 reverse stock split, reincorporation from Utah to Nevada, significant authorized share increases, adoption of a 2026 Equity Incentive Plan, and ratification of Fruci & Associates II, PPLC as independent auditors.